Robert Longtin. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useBone Neoplasms/drug therapyBone Neoplasms/geneticsBone Neoplasms/radiotherapyChromosomes, Human, Pair 11Chromosomes, Human, Pair 22Drug Industry/trendsGene Expression Regulation, Neoplastic/drug effectsHumansOncogene Proteins, Fusion/drug effectsOncogene Proteins, Fusion/geneticsPrognosisProto-Oncogene Protein c-fli-1RNA-Binding Protein EWSSarcoma, Ewing/drug therapySarcoma, Ewing/geneticsSarcoma, Ewing/radiotherapyTranscription Factors/drug effectsTranscription Factors/geneticsTranslocation, Genetic/drug effects
Substances： See more » Antineoplastic AgentsEWS-FLI fusion proteinOncogene Proteins, FusionProto-Oncogene Protein c-fli-1RNA-Binding Protein EWSTranscription Factors
Year: 2003 PMID： 14600088 DOI： 10.1093/jnci/95.21.1574
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506